Phenylketonuria Market
Sep 06, 2021
Which Pipeline Therapy is Expected to Capture the Eyeballs in the Phenylketonuria Market?
Phenylketonuria is an inherited disorder characterized by the absence or deficiency of an enzyme called phenylalanine hydroxylase (PAH), responsible for processing the amino acid phenylalanine. The condition affects one in 13,500 to 19,000 newborns in the United States, says NORD. DelveInsight’s Phenylketonuria epi...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
